Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;1(28):iv72–83. https://doi.org/10.1093/annonc/mdx220.
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538–47. https://doi.org/10.1016/s1470-2045(20)30753-1.
Mahantshetty U, Gudi S, Singh R, Sasidharan A, Sastri SC, Gurram L, Sharma D, Ganeshrajah S, Janaki MG, Badakh D, Basu A. Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachyther. 2019;11(4):293–306. https://doi.org/10.5114/jcb.2019.87406.
ICRU Report 89. Prescribing, recording, and reporting brachytherapy for cancer of the cervix. J ICRU. 2013;13(1–2):1–10. https://doi.org/10.1093/jicru/ndw042.
Dimopoulos JC, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, Pedersen EM, Van Limbergen E, Haie-Meder C, Pötter R. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol. 2012;103(1):113–22.
Article PubMed PubMed Central Google Scholar
Delclos L, Fletcher GH, Sampiere V, Grant WH III. Can the Fletcher gamma ray colpostat system be extrapolated to other systems? Cancer. 1978;41(3):970–9. https://doi.org/10.1002/1097-0142(197803)41:3%3c970::AID-CNCR2820410326%3e3.0.CO;2-D.
Article CAS PubMed Google Scholar
Jürgenliemk-Schulz IM, de Leeuw AA. The Netherlands: University Medical Center, Utrecht. gynecologic radiation therapy: novel approaches to image-guidance and management. 2011:217-23.
Smolic M, Sombroek C, Bloemers MC, van Triest B, Nowee ME, Mans A. Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator. Radiother Oncol. 2018;126(3):411–6.
Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jürgenliemk-Schulz IM. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2012;82(4):1424–30. https://doi.org/10.1016/j.ijrobp.2011.04.044.
Otter S, Coates A, Franklin A, Cunningham M, Stewart A. Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2018;17(3):580–6. https://doi.org/10.1016/j.brachy.2018.01.003.
Chen SW, Liang JA, Yang SN, Liu RT, Lin FJ. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):955–61. https://doi.org/10.1016/S0360-3016(00)00559-9.
Article CAS PubMed Google Scholar
Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, Salvajoli JV. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 2001;50(5):1123–35. https://doi.org/10.1016/s0360-3016(01)01533-4.
Article CAS PubMed Google Scholar
Sturdza A, Pötter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, Petric P, Šegedin B, Jurgenliemk-Schulz IM, Nomden C, Gillham C. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120(3):428–33. https://doi.org/10.1016/j.radonc.2016.03.011.
Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆(I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45. https://doi.org/10.1016/j.radonc.2004.12.015.
Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis. Radiother Oncol. 2021;1(158):312–20. https://doi.org/10.1016/j.radonc.2021.01.019.
Jamema SV, Kirisits C, Mahantshetty U, Trnkova P, Deshpande DD, Shrivastava SK, Pötter R. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. Radiother Oncol. 2010;97(3):501–6. https://doi.org/10.1016/j.radonc.2010.08.011.
Nomden CN, de Leeuw AA, Van Limbergen E, De Brabandere M, Nulens A, Nout RA, Laman M, Ketelaars M, Lutgens L, Reniers B, Jürgenliemk-Schulz IM. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users. Radiother Oncol. 2013;107(1):82–7. https://doi.org/10.1016/j.radonc.2012.10.002.
Comments (0)